Same Drug Class

Imatinib vs Methotrexate

Imatinib vs Methotrexate: Overview

This comparison examines the pharmacological differences between Imatinib and Methotrexate.

Mechanism of Action

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Methotrexate: Dihydrofolate reductase inhibitor.

Pharmacokinetics

Half-life: Imatinib — 18 hours; Methotrexate — 3-10 hours.

Chemical Properties

Molecular Formula: Imatinib — C29H31N7O; Methotrexate — C20H22N8O5.

Molecular Weight: Imatinib — 493.6030 g/mol; Methotrexate — 454.4400 g/mol.

Type: Imatinib — Small molecule; Methotrexate — Small molecule.